Rolaids
American antacid brand known for calcium- and magnesium-based chewable products.
Last updated August 22, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Rolaids is an American over-the-counter antacid brand whose products are formulated primarily with calcium carbonate and magnesium hydroxide. The brand is associated with chewable tablets, soft chews, and liquid antacid products intended to relieve heartburn, acid indigestion, and related symptoms. Its best-known advertising line, “How do you spell relief? R-O-L-A-I-D-S,” helped make the name part of American consumer culture and supported a long-running association with fast, accessible relief from occasional digestive discomfort. The brand originated in the late 1920s through the work of American chemist Irvine W. Grote. Manufacturing began in Chattanooga, Tennessee, through a predecessor of Chattem, the consumer-healthcare company that later became closely associated with the brand. Rolaids was manufactured for Warner-Lambert, whose consumer-healthcare portfolio included a number of widely distributed over-the-counter medicines. Warner-Lambert merged with Pfizer in 2000, placing Rolaids within Pfizer Consumer Healthcare. Rolaids changed ownership several times as the consumer-healthcare sector consolidated. In 2006, McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, acquired the brand from Pfizer Consumer Healthcare. During McNeil’s ownership, the brand introduced Extra Strength Rolaids Plus Gas Relief Softchews, a less chalky format developed from an earlier Warner-Lambert concept and test-marketed under the name Remegel in 1984. The softchew format broadened the brand beyond conventional compressed antacid tablets and was supported by advertising across multiple media. The brand suffered a major interruption beginning in 2010. McNeil voluntarily recalled Rolaids products in the Americas, the United Arab Emirates, and Fiji after consumers reported an unusual moldy, musty, or mildew-like odor. A small number of reports associated the odor with temporary, non-serious gastrointestinal symptoms, including nausea, stomach pain, vomiting, and diarrhea. A further recall later in 2010 involved foreign materials, including metal and wood particles, attributed to a third-party manufacturer. Consumer complaints included unusual taste, vomiting, and reported injury to teeth or gums. These quality and manufacturing problems contributed to the removal or substantial reduction of Rolaids products at many retailers. In 2013, McNeil sold Rolaids to Sanofi. The brand returned to the market in early September of that year under Sanofi’s Chattem operation, with revised packaging, updated trade dress, and a new liquid variety. The relaunch followed roughly two years of limited or absent availability and represented an effort to restore distribution and consumer recognition after the recalls. Rolaids products have historically been sold in numerous flavors, including original peppermint, cherry, fresh mint, fruit, tropical, punch, cool mint, berry, and apple. Rolaids also had a notable connection to professional baseball. From 1976 through 2012, the brand sponsored Major League Baseball’s Rolaids Relief Man of the Year Award, which recognized leading relief pitchers. The sponsorship linked the brand’s relief-oriented promise with a prominent sports category and became one of its most distinctive long-term marketing properties. On March 27, 2024, Procter & Gamble acquired the Rolaids brand. The transaction returned the brand to a large multinational consumer-goods company with established health-care and household distribution capabilities. Rolaids remains an active antacid brand, although its current corporate portfolio, product availability, headquarters, and full market footprint are not specified in the available reference material.
History
Rolaids developed in the United States in the late 1920s through the work of chemist Irvine W. Grote. The product was initially manufactured in Chattanooga, Tennessee, through a company that preceded Chattem. Its early commercial history was connected to Warner-Lambert, which manufactured and marketed the antacid as part of its consumer-healthcare activities. The brand’s core proposition was straightforward: provide convenient relief from heartburn and acid indigestion in a chewable dosage form based on calcium and magnesium compounds. Warner-Lambert’s ownership and manufacturing relationships placed Rolaids within the expanding American over-the-counter medicines industry. When Warner-Lambert merged with Pfizer in 2000, Rolaids moved into Pfizer Consumer Healthcare. In 2006, Johnson & Johnson subsidiary McNeil Consumer Healthcare acquired the brand from Pfizer. During this period, Rolaids extended beyond traditional chalky tablets. Pfizer introduced Extra Strength Rolaids Plus Gas Relief Softchews in April 2006, offering a softer format for consumers who disliked the texture of conventional antacids. The format had roots in an earlier Warner-Lambert product concept test-marketed under the name Remegel in Oklahoma City in 1984. Rolaids became especially recognizable through advertising. Its signature question-and-answer slogan, “How do you spell relief? R-O-L-A-I-D-S,” was used to make the brand name itself a mnemonic for symptom relief. The brand also sponsored Major League Baseball’s Rolaids Relief Man of the Year Award from 1976 through 2012. The award recognized top relief pitchers and gave Rolaids a durable association with the language of relief in professional sports. The brand’s history was disrupted by product-quality problems in 2010. On January 15, McNeil announced a voluntary recall covering Rolaids products in the Americas, the United Arab Emirates, and Fiji. The action followed consumer reports of a moldy, musty, or mildew-like smell. Although the reported gastrointestinal reactions were generally temporary and non-serious, the recall affected availability and consumer confidence. In December, another recall addressed foreign objects containing metal and wood particles that had entered products during production by a third-party manufacturer. Complaints included unusual taste, vomiting, and reported injuries involving teeth and gums. Following the recalls, much of the Rolaids line disappeared from American retail shelves or was reduced to limited formats, including small rolls and selected chewable products. The brand remained largely unavailable for approximately two years while manufacturing and quality-control issues were addressed. In 2013, McNeil sold Rolaids to Sanofi. Chattem, operating within Sanofi’s consumer-healthcare structure, brought the brand back to market in early September with new packaging, updated visual treatment, and a new liquid variety. The relaunch sought to restore the brand’s distribution after the extended interruption. Historically, Rolaids tablets have appeared in a broad range of flavors, including peppermint, cherry, fresh mint, fruit, tropical, punch, cool mint, berry, and apple. Standard formulations use calcium carbonate and magnesium hydroxide as active ingredients, while later ultra-strength versions increased the quantities of those compounds. The brand has therefore competed not only through therapeutic positioning but also through flavor, dosage strength, and dosage form. On March 27, 2024, Procter & Gamble acquired Rolaids. This latest ownership change places the brand within one of the world’s largest consumer-goods companies. The available material does not establish a current headquarters, detailed executive roster, or complete present-day product range. Rolaids is nevertheless identified as an active American antacid brand with a long history spanning independent manufacturing, Warner-Lambert, Pfizer, Johnson & Johnson’s McNeil, Sanofi’s Chattem operation, and Procter & Gamble.
- 2024
Procter & Gamble acquires Rolaids
[1]Procter & Gamble acquires the brand on March 27, 2024.
- 2013
Rolaids returns under Chattem
[1]After an extended market absence, Sanofi-owned Chattem relaunches Rolaids with new packaging, updated trade dress, and a liquid variety.
- 2012
Rolaids Relief Man of the Year Award ends
[1]The brand’s long-running Major League Baseball relief-pitching award is last presented.
- 2010
Rolaids products are recalled over odor reports
[1]McNeil recalls products in multiple markets after reports of an unusual moldy, musty, or mildew-like odor.
- 2010
Second recall addresses foreign materials
[1]A further recall concerns metal and wood particles introduced during production by a third-party manufacturer.
- 2006
McNeil acquires Rolaids
[1]Johnson & Johnson subsidiary McNeil Consumer Healthcare acquires the brand from Pfizer Consumer Healthcare.
- 2006
Extra Strength Rolaids Plus Gas Relief Softchews launches
[1]Pfizer releases a softer, non-chalky Rolaids format combining antacid action with gas-relief positioning.
- 2000
Warner-Lambert merges with Pfizer
[1]The Warner-Lambert merger with Pfizer places Rolaids within Pfizer’s consumer-healthcare portfolio.
- 1984
Softchew concept is test-marketed as Remegel
[1]Warner-Lambert test-markets an earlier soft antacid concept in Oklahoma City under the name Remegel.
- 1976
Rolaids Relief Man of the Year Award begins
[1]Rolaids begins sponsoring Major League Baseball’s award for leading relief pitchers, a relationship that continues through 2012.
Products and positioning
Fast, familiar over-the-counter relief for heartburn and acid indigestion, delivered through flavored chewable tablets, soft chews, and liquid formats.
Antacid tablets
Rolaids chewable tablets
The traditional Rolaids format consists of flavored chewable antacid tablets designed for occasional relief of heartburn, acid indigestion, and related symptoms. The active ingredients are calcium carbonate and magnesium hydroxide. Historical flavors include original peppermint, cherry, fresh mint, fruit, tropical, punch, cool mint, berry, and apple. Strengths and exact formulations have varied across product generations and ownership periods.
Softchew antacid and gas-relief product · 2006
Extra Strength Rolaids Plus Gas Relief Softchews
Introduced in 2006, this product provided an alternative to the chalky texture of standard compressed tablets. Its softchew format combined the Rolaids antacid proposition with gas-relief positioning and was promoted through broad multimedia advertising. The concept drew on an earlier Warner-Lambert product development effort that had been test-marketed as Remegel in 1984.
High-strength antacid
Rolaids Ultra Strength
Later Chattem-era varieties increased the quantities of the principal active ingredients compared with earlier formulations. The cited formulation information identifies calcium carbonate and magnesium hydroxide as the active ingredients, with ultra-strength versions reaching as much as 1,000 mg and 200 mg respectively. Availability and current formulation status are not established in the available material.
Liquid antacid · 2013
Rolaids liquid antacid
A liquid variety was introduced as part of Chattem’s 2013 relaunch. It broadened the brand’s dosage-form range beyond tablets and soft chews after the prolonged interruption in retail availability. Specific current markets, formulation details, and present availability are not provided in the reference material.
Controversies
2010
Recall over moldy or musty odor reports
McNeil recalled Rolaids products in the Americas, the United Arab Emirates, and Fiji after consumers reported an unusual moldy, musty, or mildew-like odor. A small number of reports involved temporary gastrointestinal symptoms such as nausea, stomach pain, vomiting, and diarrhea.
2010
Recall over metal and wood particles
A second recall involved foreign materials containing metal and wood particles. The materials were attributed to a third-party manufacturer, and consumer complaints included unusual taste, vomiting, and reported tooth or gum injuries.
Marketing campaigns
- 1976Rolaids Relief Man of the Year Award
United States
Rolaids sponsored Major League Baseball’s annual award for top relief pitchers. The sponsorship translated the brand’s promise of relief into a sports property centered on relief pitching.
Outcome. The award continued through 2012 and became a long-running association between Rolaids and professional baseball.
- 1970How do you spell relief?
United States
Rolaids’ best-known advertising platform used a question-and-answer device in which the brand name itself spelled relief: “R-O-L-A-I-D-S.” The campaign reinforced memorability and connected the name directly with the product benefit.
Outcome. The slogan became the brand’s signature advertising line and one of its most recognizable pieces of consumer marketing.
Brand decisions
2024
Procter & Gamble acquires the brandM&ABackground
Rolaids changed ownership after its period within Sanofi’s Chattem consumer-healthcare operation.
Action taken
Procter & Gamble acquired Rolaids on March 27, 2024.
Aftermath
The brand became part of Procter & Gamble’s multinational consumer-goods portfolio. Detailed post-acquisition operating plans are not specified in the available material.
2013
Relaunch Rolaids under ChattemStrategyBackground
After an extended market absence caused by recalls and manufacturing issues, Sanofi sought to restore the brand’s retail presence.
Action taken
Sanofi sold the brand to its Chattem operation, which returned Rolaids to market with new packaging, revised trade dress, and a liquid variety.
Aftermath
The relaunch re-established Rolaids as an active antacid brand after the prolonged interruption.
2010
Withdraw products during quality-control investigationsOtherBackground
Consumer complaints about an unusual odor led to an investigation, while subsequent manufacturing concerns involved foreign materials from a third-party producer.
Action taken
McNeil voluntarily recalled affected Rolaids products and removed or restricted products while manufacturing and quality issues were addressed.
Aftermath
The brand became difficult to find in many American retail outlets for roughly two years, with only limited formats remaining in some channels.
2006
Launch a softchew antacid and gas-relief formatProduct launchBackground
Traditional Rolaids tablets had a chalky texture that some consumers disliked. Pfizer developed a softer format intended to make the brand more accessible to those consumers.
Action taken
Pfizer introduced Extra Strength Rolaids Plus Gas Relief Softchews and supported the product with advertising across multiple media.
Aftermath
The product expanded Rolaids’ format range, although its current availability is not established in the available sources.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/rolaids · Editorial policy · How profiles are compiled